Adam Zagoria covers basketball at all levels. He is the author of two books and an award-winning journalist whose articles have appeared in ESPN The Magazine, SLAM, Sheridan Hoops, Sports Illustrated, Basketball Times and in newspapers nationwide.
Washington star Markelle Fultz questionable with sore knee
SEATTLE (AP) — Washington freshman Markelle Fultz, the leading scorer in the Pac-12 Conference and the projected No. 1 pick in the NBA Draft by DraftExpress.com, has not been cleared by team doctors to play due to a sore knee and may miss the final two regular-season games.
Coach Lorenzo Romar said Tuesday that Fultz has yet to be given clearance by the team’s medical staff to return to game action. Fultz has missed three of the past five games due to the knee issue, including last Sunday’s loss to rival Washington State.
Romar didn’t rule Fultz out for Wednesday night’s game against No. 3 UCLA but didn’t sound optimistic Fultz would be cleared in time. Washington closes out the regular season at USC on Saturday before opening the Pac-12 tournament next week in Las Vegas.
Fultz leads the conference averaging 23.2 points per game, but the Huskies have lost 10 straight.
He could become the second straight No. 1 overall pick following LSU’s Ben Simmons to miss the NCAA Tournament.
Follow Adam Zagoria on TwitterAnd like ZAGS on Facebook
Adam Zagoria is a Basketball Insider who covers basketball at all levels. A contributor to The New York Times and SportsNet New York (SNY), he is also the author of two books and is an award-winning journalist and filmmaker. His articles have appeared in ESPN The Magazine, SLAM, Sheridan Hoops, Basketball Times and in newspapers nationwide. He also won an Emmy award for his work on the SNY mini-documentary on Syracuse guard Tyus Battle.
A veteran Ultimate Frisbee player, he has competed in numerous National and World Championships and, perhaps more importantly, his teams won the Westchester Summer League (WSL) championships in 2011 and 2013.
He lives in Manhattan with his wife and children.